Applications

1230 – Testing for HER2 positivity in patients diagnosed with breast cancer to determine eligibility for treatment with trastuzumab

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Supported

Application details

Reason for application

-

Service or technology in this application

-

Medical condition this application addresses

-

Meetings to consider this application

  • PASC meeting: -
  • ESC meeting: -
  • MSAC meeting: 
    • 2 - 3 August 2012
    • 6 - 7 April 2017